Cosan (CSAN3) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
3 Feb, 2026Executive summary
EBITDA under management was R$6.0 billion, down from R$7.3 billion in 2Q24, with net income negative at R$946 million for 2Q25 and a consolidated net loss of R$2.73 billion for the first half, mainly due to impairments and operational disruptions.
Dividends and interest on capital received totaled R$579 million, a significant decrease year-over-year.
Portfolio companies showed mixed results amid macroeconomic volatility, with Rumo and Compass delivering solid operational performance, while Raízen and Moove faced operational challenges.
Major events included the acquisition of DIPI Holdings, partial disposal of Vale S.A. shares, a fire at Moove's lubricant factory, and the discontinuation of a second-generation ethanol plant.
Safety metrics improved quarter-over-quarter, with LTIF at 0.27, despite one fatality.
Financial highlights
Adjusted EBITDA under management was R$6.0 billion, down 17% year-over-year, with declines in Raízen and Compass offsetting gains in Rumo and Moove.
Net debt at Cosan Corporate remained stable at R$17.5 billion, with gross debt decreasing by R$4.1 billion year-over-year due to liability management.
Debt Service Coverage Ratio (DSCR) was 1.2x LTM, unchanged from the previous quarter.
Average debt cost decreased to CDI plus 0.88%, with an average maturity above six years.
Dividends from Radar and Moove were significant cash inflows, while interest payments and principal amortization were notable cash outflows.
Outlook and guidance
Management expects continued volatility due to restrictive interest rates, tax changes, and international tariffs, but remains focused on cost discipline, portfolio optimization, and capital structure strengthening.
No specific forward guidance on insurance claim monetization or dividend payouts; ongoing monitoring of regulatory changes and market diversification strategies.
Latest events from Cosan
- EBITDA and net income fell, but major asset sales and capital raises improved leverage and liquidity.CSAN3
Q4 20259 Jul 2026 - Net loss reached R$1.8B, EBITDA fell 30%, but net debt dropped to R$17.5B after asset sales.CSAN3
Q1 20258 Jul 2026 - EBITDA rose, net income fell, and management changes and acquisitions shaped the quarter.CSAN3
Q3 20242 Jul 2026 - EBITDA rose 15% to R$7.1bn, net loss narrowed, and capital discipline remained strong.CSAN3
Q2 20242 Jul 2026 - Net revenue rose 11%, but large impairments led to a R$9.4 billion net loss in 2024.CSAN3
Q4 20242 Jul 2026 - Net loss narrowed to R$1.6 billion, with strong EBITDA and major deleveraging actions.CSAN3
Q1 202622 May 2026 - EBITDA and net income declined, but R$10.5 billion equity raised improved capital structure.CSAN3
Q3 20253 Feb 2026